News From The Journals Of The American Society For Microbiology
10/23/2011
Human Norovirus In Groundwater Remains Infective After Two Months Researchers from Emory University have discovered that norovirus in groundwater can remain infectious for at least 61 days. The research is published in the October Applied and Environmental Microbiology. Human norovirus is the most common cause of acute gastroenteritis...
'Pushing Limits' - New Drug Strategies For Alzheimer's, Multiple Sclerosis
10/23/2011
Researchers at the University of Houston (UH) are recommending a new strategy for developing drugs to treat cancer, multiple sclerosis, Alzheimer's and cardiovascular diseases...
Association Between Alcohol And Cancer Mortality
10/23/2011
A paper from the National Institutes of Health in the United States has evaluated the separate and combined effects of the frequency of alcohol consumption and the average quantity of alcohol drunk per occasion and how that relates to mortality risk from individual cancers as well as all cancers...
Lung Cancer Vaccine Boosts Progression Free Survival
10/22/2011
An experimental vaccine, called TG4010, given together with chemotherapy resulted in significantly more progression free survival in patients with advanced lung cancer compared to those on chemotherapy alone, researchers from the Université de Strasbourg in Strasbourg, France, reported in the journal The Lancet Oncology...
Lung Cancer Vaccine Boosts Progression Free Survival
10/22/2011
An experimental vaccine, called TG4010, given together with chemotherapy resulted in significantly more progression free survival in patients with advanced lung cancer compared to those on chemotherapy alone, researchers from the Université de Strasbourg in Strasbourg, France, reported in the journal The Lancet Oncology...
Research Involving Thyroid Hormone Lays Foundation For More Targeted Drug Development
10/22/2011
Research led by St. Jude Children's Research Hospital scientists advances a strategy for taming the side effects and enhancing the therapeutic benefits of steroids and other medications that work by disrupting the activity of certain hormones. The approach relies on a small molecule developed at St. Jude...
OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that it has initiated patient enrollment in a randomized, Phase II clinical trial evaluating OGX-427, an inhibitor of heat shock protein 27 (Hsp27), in patients with advanced bladder cancer...
Surgeon Removes Eight Pound Liver Tumor
10/22/2011
The cancerous tumor in Marcus Muhich's liver weighed 8 pounds and was nearly a foot across. Doctors at three major academic medical centers in the Midwest told Muhich his high-grade tumor was inoperable. Then he was referred to Dr. Margo Shoup, chief of the Division of Surgical Oncology at Loyola University Medical Center...
Research Involving Thyroid Hormone Lays Foundation For More Targeted Drug Development
10/22/2011
Research led by St. Jude Children's Research Hospital scientists advances a strategy for taming the side effects and enhancing the therapeutic benefits of steroids and other medications that work by disrupting the activity of certain hormones. The approach relies on a small molecule developed at St. Jude...
Biomarker Detects Graft-Versus-Host-Disease In Cancer Patients After Bone Marrow Transplant
10/22/2011
A University of Michigan Health System-led team of researchers has found a biomarker they believe can help rapidly identify one of the most serious complications in patients with leukemia, lymphoma and other blood disorders who have received a transplant of new, blood-forming cells...